Compare American States Water Company (AWR) vs BridgeBio Pharma Inc (BBIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American States Water Company vs BridgeBio Pharma Inc — how do they compare? American States Water Company trades at $87.53 (market cap $3.47B), while BridgeBio Pharma Inc trades at $83.86 (market cap $16.36B). The key difference: BridgeBio Pharma Inc is far larger — about 4.7× American States Water Company's market cap, and American States Water Company pays a 2.49% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| AWR | BBIO | |
|---|---|---|
Market Cap | $3.47B | $16.36B |
Sector | Utilities | Health |
52-Week High | $89.28 | $90.17 |
52-Week Low | $70.10 | $47.29 |
Enterprise Value | $4.37B | $18.14B |
Dividend Yield | 2.49% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American States Water Company
American States Water provides water and electric services to over one million people in the U.S. It also manages water and wastewater systems for various military bases under long-term privatization contracts.
Read more on AWR →About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →
